[go: up one dir, main page]

AU4941297A - A method for promoting tissue repair - Google Patents

A method for promoting tissue repair

Info

Publication number
AU4941297A
AU4941297A AU49412/97A AU4941297A AU4941297A AU 4941297 A AU4941297 A AU 4941297A AU 49412/97 A AU49412/97 A AU 49412/97A AU 4941297 A AU4941297 A AU 4941297A AU 4941297 A AU4941297 A AU 4941297A
Authority
AU
Australia
Prior art keywords
tissue repair
promoting tissue
promoting
repair
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49412/97A
Inventor
Thorsten Jorgensen
Judi Moss
Henrik Vigan Nicolajsen
Lise Sylvest Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Dumex AS
Dumex Alpharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex AS, Dumex Alpharma AS filed Critical Dumex AS
Publication of AU4941297A publication Critical patent/AU4941297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU49412/97A 1996-11-15 1997-11-14 A method for promoting tissue repair Abandoned AU4941297A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK129796 1996-11-15
DK1297/96 1996-11-15
US3544497P 1997-01-30 1997-01-30
US60035444 1997-01-30
PCT/DK1997/000525 WO1998022114A1 (en) 1996-11-15 1997-11-14 A method for promoting tissue repair

Publications (1)

Publication Number Publication Date
AU4941297A true AU4941297A (en) 1998-06-10

Family

ID=26065547

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49412/97A Abandoned AU4941297A (en) 1996-11-15 1997-11-14 A method for promoting tissue repair

Country Status (2)

Country Link
AU (1) AU4941297A (en)
WO (1) WO1998022114A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147860A1 (en) 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
EP1083906A4 (en) * 1998-06-04 2003-03-26 Nutramax Lab Inc Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
DE19826503A1 (en) 1998-06-13 1999-12-16 Beiersdorf Ag Cosmetic and dermatological preparations containing chitosan and phospholipids
FR2791262B1 (en) * 1999-03-22 2001-09-28 Virbac Sa COMPOSITIONS BASED ON CHONDROITINE AND CHITOSAN FOR THE PROTECTION, TREATMENT OR REPLACEMENT OF CONNECTIVE TISSUES
CA2377435A1 (en) 1999-06-29 2001-01-04 J. Alexander Marchosky Compositions and methods for forming and strengthening bone
ES2491866T3 (en) 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Temperature-controlled, pH-dependent, self-gelling aqueous biopolymer solution
ATE320277T1 (en) 2000-06-29 2006-04-15 Biosyntech Canada Inc COMPOSITION AND METHOD FOR REPAIR AND REGENERATION OF CARTILAGE AND OTHER TISSUES
ITMI20012188A1 (en) * 2001-10-19 2003-04-19 Interalta S R L SILVER SALTS OF SACCHAROSE - OTTO-SULFATE
WO2003055536A1 (en) * 2001-12-21 2003-07-10 Coloplast A/S A wound care device
EP1539799B1 (en) 2002-06-21 2013-12-11 The University of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
US20040019022A1 (en) * 2002-07-25 2004-01-29 Karen Stec Use of 2,3 alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular dysfunction, damage and injury in mammals
JP2007500196A (en) 2003-05-24 2007-01-11 バイヤースドルフ・アクチエンゲゼルシヤフト Tissue culture medium used as a cosmetic ingredient
US8039017B2 (en) 2003-06-19 2011-10-18 Coloplast A/S Wound care device
EP1609462B1 (en) * 2004-04-22 2015-07-29 La Prairie Group AG Cosmetic or dermatological preparation comprising a nutrient medium phase
CA2623475A1 (en) * 2005-09-28 2007-04-05 Dnp Canada Inc. Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia
ES2327480B1 (en) * 2007-06-15 2010-08-10 Bioiberica, S.A. "DISABLED FOR THE TREATMENT OF TENDONS, LIGAMENTS AND BONES".
ES2619181T3 (en) 2007-08-28 2017-06-23 Otago Innovation Limited Surgical hydrogel
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
EP2632502B1 (en) 2010-10-27 2015-05-06 Medtronic, Inc. Artificial scab for use in an airway
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
CN102440959B (en) * 2011-11-29 2013-01-23 海南灵康制药有限公司 Pidotimod liposome solid preparation
FR2991876B1 (en) 2012-06-13 2014-11-21 Vivacy Lab COMPOSITION, IN AQUEOUS MEDIUM, COMPRISING AT LEAST ONE HYALURONIC ACID AND AT LEAST ONE WATER-SOLUBLE SALT OF SUCROSE OCTASULFATE
FR2993182B1 (en) 2012-07-13 2014-10-17 Urgo Lab DRESSING WITH PROLONGED RELEASE OF ASSETS
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
FR3044555B1 (en) * 2015-12-07 2020-03-06 Centre National De La Recherche Scientifique - Cnrs - FILM COMPRISING AN OLIGOSACCHARIDE POLYSULFATE AND A POLYCATION AND METHOD FOR THE PRODUCTION THEREOF
BR112018013919A2 (en) * 2016-01-07 2018-12-11 Zeltiq Aesthetics Inc temperature dependent adhesion between applicator and skin during tissue cooling
IT201700047632A1 (en) * 2017-05-03 2018-11-03 Ricerfarma Srl TOPIC COMPOSITIONS TO MAINTAIN AND RESTORE THE HYDRO-MOISTIC SKIN HOMEOSTASIS
CN114028345B (en) * 2021-11-18 2023-02-28 海南海灵化学制药有限公司 Aspoxicillin freeze-dried agent for injection and preparation process thereof
CN114887121B (en) * 2022-04-14 2023-04-07 广东粤港澳大湾区国家纳米科技创新研究院 Colloidal fluid of artesunate-nanogold compound, preparation method thereof and antibacterial product
CN118022064B (en) * 2024-02-29 2024-08-16 海口市人民医院（中南大学湘雅医学院附属海口医院） A NPP/C-HA/rhBMP-2 composite scaffold and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937283A1 (en) * 1989-11-09 1991-05-16 Hoechst Ag POLYELECTROLYTE COMPLEXES FOR TREATING AND PROPHYLAXIS OF VIRUS DISEASES, NEW POLYELECTROLYTE COMPLEXES AND METHOD FOR THE PRODUCTION THEREOF
EP0454044B1 (en) * 1990-04-25 1995-12-06 Hoechst Aktiengesellschaft Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
JPH04185601A (en) * 1990-11-20 1992-07-02 Unitika Ltd Sustained release preparation containing platinum anticancer drug
SE518597C2 (en) * 1994-05-04 2002-10-29 Medicarb Ab Use of chitosan in combination with a sulfated, negatively charged polysaccharide for the preparation of a dental active oral hygiene composition for the treatment of periodontitis, plaques and / or caries

Also Published As

Publication number Publication date
WO1998022114A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
AU4941297A (en) A method for promoting tissue repair
AU1995297A (en) Method for laser surgery
AU4341697A (en) A biometric based method for software distribution
AU9227198A (en) A method for improving skin condition
AU4704397A (en) A brush and method for producing same
EP0904362A4 (en) Method for transforming plant tissue
AU7848598A (en) Method for disassembling different elements
SG55308A1 (en) Method for offering a phantom target
EP0821059B8 (en) Method for reverse transcription
AU5252396A (en) Method for preparing a modified solid oxide
AU6254096A (en) A tissue repair patch
AU4086997A (en) Method for making a diamond-coated member
AU5751298A (en) Method for producing arylcyanates
AU5317398A (en) Method for preparing cyclopropylamines
AU9252198A (en) Method for positioning engraving organs
AU6627698A (en) Method for sterilising a sample
AU2912697A (en) Drive for a generator
AU2183997A (en) New method
AU3704297A (en) Method
AU3814497A (en) Method for immunosuppressing
AU2991497A (en) Method for odor reduction
AU2010097A (en) A method for preparing 3-amino substituted crotonates
AU9013498A (en) Method for a bending procedure
AU5854598A (en) Method for producing 1-phenyl-uracil derivatives
AU2213697A (en) A method for periodontal disease treatment